Contrast Media Injectors Market to be sold this year, 2023, is around US$ 1.6 Billion. Furthermore, the global contrast media injector market is predicted to reach approximately US$ 3 Billion by 2033 following a yearly growth rate of 6.6%.
Increasing trauma cases globally is expected to boost the growth of the contrast media injectors market. Additionally, the increasing prevalence of cancer among the geriatric population globally is expected to drive demand for the contrast media injectors market.
Furthermore, as the number of cancer, neurological, and cardiovascular patients admitted to hospitals rises, the industry will experience significant growth. With the vast range of applications in radiology, interventional radiology, and interventional cardiology, hospitals are the principal users of high-pressure contrast media injectors.
End-user demand for technologically improved contrast media injectors, such as IT-enabled contrast media injectors that can connect to a hospital database for dosage monitoring, is driving up contrast media injector prices.
Radiology Contrast Injectors, also known as contrast delivery systems, are devices used in medical imaging to inject contrast media into a patient’s bloodstream. Contrast media are substances that are used to make certain tissues or organs more visible on medical images, such as X-rays, CT scans, and MRI scans.
Request Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-823
Air emboli formed during contrast media injection can restrict right ventricular outflow or clog pulmonary arterioles, resulting in significant complications such as cardiovascular collapse.
Key Takeaways from the Contrast Media Injectors Market Study Report
The United States is the leading market with a market share of 32.5%, which is around US$ 500 Mn in 2023. The demand for contrast media injectors in the country is projected to grow at a rate of 6.8% from 2023 to 2033.
In Europe, Germany is the dominant market and is projected to register a CAGR of 6.3% from 2023 to 2033. It is the second-largest market in the world and is predicted to reach US$ 202.9 Mn by the end of 2033.
While. the demand for contrast media injectors in the United Kingdom is growing faster than in Germany. The report predicts the growth rate for the UK market to be 6.4% through 2033 to reach a valuation of US$ 123.3 Mn.
Meanwhile, China is the fastest-growing region in the production and sales of contrast media injectors around the world. By registering a CAGR of 7.8% over the forecast years, this regional market is estimated to reach US$ 192.3 Mn by 2033.
India is emerging as a promising market with growing demand for contrast media injectors. The growth rate estimated for this regional market is around 5.4%, and the net worth of the market is to reach US$ 42.5 Mn by 2033.
Have a Conversation with the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-823
Among the different types of contrast media injectors available in the market, CT injectors are the top-performing product type segment. This segment is projected to grow at a rate of 6.4% during the time period covering 2023 to 2033.
For the contrast media injectors market players, the hospital segment is predicted to remain the prominent end-user vertical. During the forecast period, this segment is expected to witness a year-on-year growth rate of 6.7% from 2023 to 2033.
Competitive Landscape for the Contrast Media Injectors Market
Some of the key players operating in the global media injectors market are Bayer AG, NemotoKyorindo Co. Ltd., Mallinckrodt, Bracco Imaging, Ulrich GmBh, Guerbet SA, Medtronic AG, Sino Medical-device Technology Co., Ltd, and Apollo RT Co., Ltd among others.
Recent Developments in the Contrast Media Injectors Industry
- In May 2021, Bayer AG announced a collaboration with ArcherDX, Inc., which will focus on the global development and commercialization of therapy-accompanying diagnostic tests – also known as companion diagnostics (CDx) – for Vitrakvi™ (larotrectinib), based on next-generation sequencing.
- In May 2019, the Ulrich’s CT contrast agent injector, CT motion, was made available in the world’s most important medical technology market, the U.S.
Key Companies Profiled:
- Mallinckrodt (Guerbet SA)
- GE Healthcare
- Bayer AG
- Ulrich GmbH & Co. KG
- Bracco Imaging S.p.A
- Medtron
- NemotoKyorindo Co. Ltd
- Shenzhen Anke High-tech Co. Ltd
- Sino Medical-device Technology Co., Ltd
- Apollo RT Co., Ltd
Order a Complete Research Report @ https://www.futuremarketinsights.com/checkout/823
Contrast Media Injectors Market by Category
By Product Type:
- CT Injectors
- MRI Injectors
- Cardio Injectors
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostics Centers
- Others
Have a Look at Related Research Reports of the Healthcare Domain:
- https://janjaonline.mn.co/posts/cosmetic-implants-market-is-predicted-to-procure-usd-179-billion-from-2022-to-2032
- https://masterpaper.mn.co/posts/33364051
- https://waoop.com/read-blog/52159_cosmetic-implants-market-is-predicted-to-procure-usd-17-9-billion-from-2022-to-2.html
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
